Christopher Pack, Ph.D.
Director, Preclinical Studies
Dr. Pack has over 20 years of training and expertise in vaccine design and CD8+ T cell biology. He received his Ph.D. from the University of Tennessee where he studied neonatal vaccine design against Herpes Simplex Virus-1 in the laboratory of Dr. Barry T. Rouse. After earning his doctorate degree, Dr. Pack:
- Studied CD8+ T cell memory formation during persistent oncogenic viral infection at Emory University in the lab of Dr. Aron Lukacher.
- Joined Metaclipse in 2012 to lay the preclinical groundwork for the TNBC approach
- Has served as the Principal Investigator (PI) for the phase I SBIR grant focused on proof-of-concept studies to treat TNBC and the Co-PI for the phase II product development grant
- Has led the preclinical research division at Metaclipse Therapeutics